North America Sartans Market: Losartan, Valsartan, Telmisartan & Competitive Analysis
North America represents a significant market for sartans, driven by the high prevalence of hypertension and cardiovascular diseases across the region. Growing demand for angiotensin II receptor blockers, increasing awareness of blood pressure management, and established healthcare infrastructure are supporting market growth. The availability of generic medications and continued improvements in...
0 Σχόλια 0 Μοιράστηκε 18 Views 0 Προεπισκόπηση